Top compounds associated with response to LMNTD2


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.0079 0.8
mRNA ML311 CTRPv2 pan-cancer AAC 0.0071 0.8
mRNA Docetaxel CTRPv2 pan-cancer AAC -0.01 0.8
mRNA JW-7-52-1 GDSC1000 pan-cancer AAC -0.011 0.8
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0081 0.8
mRNA canertinib CTRPv2 pan-cancer AAC 0.0077 0.8
mRNA Topotecan CTRPv2 pan-cancer AAC 0.0068 0.8
mRNA chlorambucil CTRPv2 pan-cancer AAC -0.0067 0.8
mRNA RO-3306 GDSC1000 pan-cancer AAC -0.0075 0.8
mRNA PD-0325901 GDSC1000 pan-cancer AAC -0.0069 0.8
Download CSV